HON vs NKE: Which Is the Better Buy?

Side-by-side comparison of Honeywell International Inc. and NIKE, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-14.
Honeywell International Inc. Β· Industrials
$222.25
-5.5% upside to fair value
Grade D High Quality
VS
NIKE, Inc. Β· Consumer Cyclical
$41.05
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
NKE has more upside to fair value (+45.0%). HON trades at a lower forward P/E (15.7x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric HON NKE
Current Price $222.25 $41.05
Fair Value Estimate $210.05 $59.52
Upside to Fair Value -5.5% +45.0%
Market Cap $70.4B $60.7B
Forward P/E 15.7x 19.6x
EV / EBITDA 13.1x 14.2x
Price / Sales 1.9x 1.3x
Price / FCF 17.1x 57.9x
Revenue Growth YoY -6.9% -1.1%
Gross Margin 36.9% 42.9%
Operating Margin 14.9% 8.2%
Return on Equity 23.6% 22.0%
Dividend Yield 0% 0%
FCF Yield 5.84% 1.73%
Analyst Consensus Strong Buy Hold
Investment Thesis
HON β€” Honeywell International Inc.
Honeywell International Inc. operates as a diversified industrial conglomerate with a strong presence in multiple sectors including aerospace, building technologies, and performance materials. The company demonstrates high business quality with a durable competitive moat supported by strong margins, a 23.6% return on equity, and solid free cash flow generation of $16.78 per share. However, recent…
NKE β€” NIKE, Inc.
NIKE, Inc. is a leading global athletic footwear and apparel company with a durable competitive moat supported by its strong brand, scale, and global distribution infrastructure. The company is currently led by CEO Elliott Hill, a seasoned Nike veteran who returned in October 2024 to navigate intensifying competition and channel complexity. Despite its market leadership and solid profitability me…
Accumulation Zones
Metric HON NKE
Zone Low $157.54 $44.64
Zone High $178.54 $50.59
In Buy Zone? No Yes
← HON Research    NKE Research β†’    All Research